Protein insufficiency
Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Health Conditions A-Z Health & Wellness Nutrition Fitness Health News Ayurveda Videos Medicine A-Z Parenting Login to get the latest articles, videos, gallery, and a lot more or continue with Email Google Facebook To get Registered Signup now Credit: iStock Rachel V Thomas Updated Apr 16, 2026 | 04:00 PM IST Summary Patients taking semaglutidethe active ingredient in the popular weight loss drugsshowed improvements in the fatty liver condition that went beyond what could be explained by blood sugar control and weight loss alone
1-4 PIONEER 2: In an open-label trial with a primary endpoint of mean change in A1C from baseline to Week 26, 822 adult patients with type 2 diabetes receiving metformin were randomized to semaglutide tablets 14 mg (n=412) or Jardiance 25 mg (n=410), both once daily
